Research / Scientific departments / Immunology / Dendritic Cell Immunobiology / Lab members

Team past and present

The LAB

To contact the lab :
Phone : (33) 1 44 38 95 02
Fax : (33) 1 45 68 85 48

	Matthew ALBERT Head of Lab, INSERM Head of the Immunology Department Head of the Center for Human Immunology (CIH)		Cécile ALANIO, MD PhD student, INCa Ecole Doctorale 394, Physiologie et Physiopathologie
	Charlotte AURIAU Animal technician, Inserm		Rosa BARREIRA DA SILVA, PhD Postdoc, Inserm
	Aurélie BISIAUX Research engineer, Institut Pasteur		Tracy CANTON Animal Technician, Inserm
	Armanda Casrouge Research engineer, INSERM		Darragh DUFFY, PhD Projects Manager for FP7-funded Hepatitis C Inserm CV
	Marie-Laure GOUPIL Administrative support, Institut Pasteur		Molly INGERSOLL, PhD Senior scientist, Université Paris Descartes Urinary tract infection and bladder cancer studies
	Pierre-Emmanuel JOUBERT, PhD Postdoc, Institut Pasteur		Gabriela MORA PhD Student, Institut Pasteur PhD International Programme Ecole Doctorale 394, Physiologie et Physiopathologie
	Brieuc PEROT PhD Student, Cancéropôle Ile-de-France Ecole Doctorale 394, Physiologie et Physiopathologie		Hélène SAKLANI Research engineer, Institut Pasteur
	Philippe SULTANIK, MD PhD student, ANRS Ecole Doctorale B3MI (ED 516)		Stéphanie THOMAS Lab Projects Manager, Inserm
	Alejandra URRUTIA Research engineer, INSERM		Nader YATIM MD-PhD student, INCa École de l'Inserm Liliane Bettencourt Ecole Doctorale 474, Interdisciplinaire Européenne Frontières du Vivant
	Biljana ZAFIROVA, PhD Postdoc, Marie Curie

Our past successful lab PhD students

	Claire BIOT Successfully defended her PhD in 2012	BCG immunotherapy for bladder cancer: characterization and modeling of the bladder immune response to BCG identify strategies to improve the anti-tumor response.
	Isabelle BOUVIER Successfully defended her PhD in 2012	Voie d'immunisation et séquence d'administration de l'antigène et de l'adjuvant: facteurs critiques pour une réponse lymphocytaire T efficace. Route of immunization and timing of adjuvant delivery are critical factors for efficient T cell cross-priming.
	Huey-Hsuan CHANG Successfully defended her PhD in 2009	Mécanisme d’action du BCG dans le traitement intravésical des patients atteints du cancer superficiel de la vessie: Rôle de l’interferon et des gènes induits par l’interferon dans la réponse innée induite par le BCG. Defining the mechanism of action of intravesical therapy in patients with superficial transitional cell carcinoma of the bladder: A role for interferons and interferon stimulated genes in the innate immune response to BCG.
	Jérémie DECALF Successfully defended his PhD in 2010	Les cellules dendritiques plasmacytoïdes au cours de l’infection chronique par le virus de l’hépatite C : De l’immunologie fondamentale à l’application dans le développement de nouvelles thérapies
	Randy LONGMAN Successfully defended his PhD in 2006	Dendritic cells mediate the dual effects of IFNa/b in HCV immunity
	Hala MANSOUR Successfully defended her PhD in 2010	Defining the role of Plasmacytoid dendritic cells and Type 1 Interferon in Acute Hepatitis C Patients
	Clémentine SCHILTE Successfully defended her PhD in 2010	Rôle de l’interferon de type 1 dans la physiologie du virus du Chikunguyna. Physiopathology of chikungunya virus: the role of type 1 Interferon.